Ticker
PHVS
Analysis
Pharvaris N.v. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to PHVS.
Pharvaris N.v. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to PHVS.
PHVS
Stock
$2.15B
Health Technology
Biotechnology
USD
Pharvaris N.v. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.
Results from prespecified assessment of End of Progression™ in the RAPIDe-3 Phase 3 study and clinical relevance of this newly-defined endpoint detailed in an oral presentationE...
ZUG, Switzerland, June 11, 2026 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to...
Pharvaris to Present Clinical Data at the EAACI Annual Congress 2026
Pharvaris Reports First Quarter 2026 Financial Results and Provides Business
ZUG, Switzerland, May 11, 2026 (GLOBE NEWSWIRE) -- Pharvaris N.V. (“Pharvaris,” Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 recept...
Review valuation context for Pharvaris N.v..
Review future growth context for Pharvaris N.v..
Review past performance context for Pharvaris N.v..
Review financial health context for Pharvaris N.v..
Review dividend context for Pharvaris N.v..
Review management context for Pharvaris N.v..
Review ownership context for Pharvaris N.v..
Review other information context for Pharvaris N.v..
Review community context for Pharvaris N.v..